{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:10:22Z","timestamp":1785539422235,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejim.2026.106830","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:25:12Z","timestamp":1773491112000},"page":"106830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Guideline-directed medical therapy and mortality in heart failure patients hospitalized for COPD exacerbation"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-476X","authenticated-orcid":false,"given":"Delphine","family":"Vauterin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-7651","authenticated-orcid":false,"given":"Frauke","family":"Van Vaerenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Grymonprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo M.","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-4363","authenticated-orcid":false,"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106830_bib0001","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0002","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2026 Report."},{"key":"10.1016\/j.ejim.2026.106830_bib0003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2026.106830_bib0004","article-title":"Personalizing the approach for the diagnosis of patients with concomitant chronic obstructive pulmonary disease and heart failure","volume":"252","author":"Abou-Rjeili","year":"2025","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0005","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106830_bib0006","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.202307-1122OC","article-title":"Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study","volume":"209","author":"Graul","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0007","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/rccm.202407-1320ST","article-title":"A research agenda to improve outcomes in patients with chronic obstructive pulmonary disease and cardiovascular disease - an official American thoracic society research statement","volume":"210","author":"Myers","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2026.106830_bib0009","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/heartjnl-2016-309458","article-title":"Underuse of \u03b2-blockers in heart failure and chronic obstructive pulmonary disease","volume":"102","author":"Lipworth","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2026.106830_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106800","article-title":"Heart failure in patients with COPD exacerbations: looking below the tip of the iceberg","volume":"196","author":"Hesse","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0011","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.amjcard.2007.08.046","article-title":"Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure","volume":"101","author":"Rusinaru","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2026.106830_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059122","article-title":"Impact of COPD and asthma on in-hospital mortality and management of patients with heart failure in England and Wales: an observational analysis","volume":"12","author":"Gulea","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejim.2026.106830_bib0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12931-020-1312-7","article-title":"Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis","volume":"21","author":"Axson","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.ejim.2026.106830_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-003110","article-title":"Increased in-hospital mortality and readmission risk associated with cardiovascular and cerebrovascular comorbidities in acute exacerbation of COPD patients","volume":"12","author":"Feng","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.ejim.2026.106830_bib0015","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.18632\/aging.102004","article-title":"Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap","volume":"11","author":"Su","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.ejim.2026.106830_bib0016","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ejhf.70046","article-title":"Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: cardiovascular and respiratory outcomes","volume":"27","author":"Beer","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2026.106830_bib0017","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ejhf.519","article-title":"Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009","volume":"18","author":"Staszewsky","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2026.106830_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001569","article-title":"Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis","volume":"10","author":"Lv","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.ejim.2026.106830_bib0019","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction","volume":"10","author":"Tromp","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ejim.2026.106830_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108337","article-title":"Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States","volume":"248","author":"Bhutani","year":"2025","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0021","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.106830_bib0025","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106830_bib0026","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2017 Report."},{"key":"10.1016\/j.ejim.2026.106830_bib0027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-2466-14-151","article-title":"Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease","volume":"14","author":"Hasegawa","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0028","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1007\/s11606-025-09660-x","article-title":"Derivation and validation of a new score for predicting in-hospital mortality in exacerbations of chronic obstructive pulmonary disease","volume":"40","author":"Peng","year":"2025","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/COPD.S51467","article-title":"Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD)","author":"Wang","year":"2014","journal-title":"Int J Chron Obs Pulmon Dis"},{"key":"10.1016\/j.ejim.2026.106830_bib0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12890-023-02426-3","article-title":"In-hospital antibiotic use for severe chronic obstructive pulmonary disease exacerbations: a retrospective observational study","volume":"23","author":"Vanoverschelde","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/15412555.2011.650239","article-title":"Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality","volume":"9","author":"Perera","year":"2012","journal-title":"Copd"},{"key":"10.1016\/j.ejim.2026.106830_bib0032","first-page":"823","article-title":"Diagnostic and therapeutic gaps in patients with heart failure and chronic obstructive pulmonary disease","volume":"7","author":"Canepa","year":"2019","journal-title":"Heart Fail"},{"key":"10.1016\/j.ejim.2026.106830_bib0033","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/eurjpc\/zwaf119","article-title":"Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study","volume":"32","author":"Gale","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"10.1016\/j.ejim.2026.106830_bib0034","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1513\/AnnalsATS.201407-311OC","article-title":"Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease","volume":"11","author":"Lindenauer","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ejim.2026.106830_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/COPD.S122354","article-title":"Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD","volume":"12","author":"Bishwakarma","year":"2017","journal-title":"Int J Chron Obs Pulmon Dis"},{"issue":"1","key":"10.1016\/j.ejim.2026.106830_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40801-019-00171-w","article-title":"Comparative causal analysis of the effects of long-acting muscarinic antagonist versus no long-acting bronchodilator use on readmission or mortality after hospitalization for chronic obstructive pulmonary disease","volume":"7","author":"Roberts","year":"2020","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.ejim.2026.106830_bib0037","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2147\/COPD.S510613","article-title":"Quality of care and outcomes of inpatients with COPD: a multi-center study in China","volume":"20","author":"Wang","year":"2025","journal-title":"Int J Chron Obs Pulmon Dis"},{"key":"10.1016\/j.ejim.2026.106830_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1174148","article-title":"Management of acute COPD exacerbations in the internal medicine departments in Israel-a national survey","volume":"10","author":"Bar-Shai","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0039","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.202312-2311OC","article-title":"Effect of triple therapy on cardiovascular and severe cardiopulmonary events in chronic obstructive pulmonary disease: a post hoc analysis of a randomized, double-blind, phase 3 clinical trial (ETHOS)","volume":"211","author":"Singh","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejim.2024.07.001","article-title":"Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: the ICSLIFE pragmatic, randomised controlled study","volume":"128","author":"Papi","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.ejim.2026.106830_bib0041","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.202407-1494ED","article-title":"The role of inhaled corticosteroids in reducing cardiovascular risk: seeing is not always believing","volume":"211","author":"Quint","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0042","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40256-025-00732-1","article-title":"Appraisal of \u03b2-blocker use in patients with cardiovascular disease and chronic obstructive pulmonary disease","volume":"25","author":"Xue","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ejim.2026.106830_bib0043","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.2147\/IJGM.S295467","article-title":"Optimal management of heart failure and chronic obstructive pulmonary disease: clinical challenges","volume":"15","author":"Cuthbert","year":"2022","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0044","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12931-021-01661-8","article-title":"Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison","volume":"22","author":"Gulea","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.ejim.2026.106830_bib0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-8703(99)70134-1","article-title":"Beta-blocker withdrawal: the song of Orpheus","volume":"138","author":"Eichhorn","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2026.106830_bib0046","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/ejhf.2888","article-title":"Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: a scientific statement by the heart failure association of the ESC","volume":"25","author":"Metra","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"10.1016\/j.ejim.2026.106830_bib0047","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejim.2026.106830_bib0048","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"issue":"10030","key":"10.1016\/j.ejim.2026.106830_bib0049","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.106830_bib0050","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","article-title":"An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal","volume":"204","author":"Celli","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2026.106830_bib0051","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1164\/rccm.202209-1795CI","article-title":"Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: best practice","volume":"207","author":"Celli","year":"2023","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:10:57Z","timestamp":1780139457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"alternative-id":["S0953620526001354"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106830","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline-directed medical therapy and mortality in heart failure patients hospitalized for COPD exacerbation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106830"}}